Arcellx (ACLX) Non-Current Deffered Revenue (2021 - 2025)

Arcellx's (ACLX) quarterly Non-Current Deffered Revenue came in at $53.1 million in Q4 2025, down 30.13% year-on-year from $76.0 million in Q4 2024, and up 1.28% quarter-over-quarter from $52.4 million in Q3 2025.

Arcellx (ACLX) Non-Current Deffered Revenue (2021 - 2025) Analysis & Trends

Arcellx's Non-Current Deffered Revenue history runs 4 years deep, the most recent figure standing at $53.1 million for Q4 2025.

  • On a quarterly basis, Non-Current Deffered Revenue fell 30.13% year-over-year to $53.1 million in Q4 2025; TTM through Dec 2025 was $53.1 million, a 30.13% decrease from a year earlier, with the FY2025 full-year figure at $53.1 million, down 30.13% from the prior year.
  • Non-Current Deffered Revenue advanced to $53.1 million in Q4 2025 per ACLX's latest filing, from $52.4 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $170.7 million in Q4 2023 and bottomed at $1.9 million in Q4 2021.
  • The 4-year median for Non-Current Deffered Revenue is $82.6 million (2024), against an average of $86.6 million.
  • Biggest YoY gain for Non-Current Deffered Revenue was 5.96% in 2024; the steepest drop was 55.47% in 2024.
  • Year by year, Non-Current Deffered Revenue stood at $1.9 million in 2021, then jumped by 8906.49% to $170.7 million in 2023, then plunged by 55.47% to $76.0 million in 2024, then tumbled by 30.13% to $53.1 million in 2025.
  • Per Business Quant, the three latest ACLX Non-Current Deffered Revenue figures stand at $53.1 million (Q4 2025), $52.4 million (Q3 2025), and $59.9 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Arcellx 6.48 Bn 6.48 Bn - 53.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 53.10 Mn
Sep 30, 2025 52.43 Mn
Jun 30, 2025 59.92 Mn
Mar 31, 2025 69.45 Mn
Dec 31, 2024 76.00 Mn
Sep 30, 2024 82.61 Mn
Jun 30, 2024 96.08 Mn
Mar 31, 2024 112.07 Mn
Dec 31, 2023 170.67 Mn
Sep 30, 2023 121.09 Mn
Jun 30, 2023 124.27 Mn
Mar 31, 2023 105.76 Mn
Dec 31, 2021 1.90 Mn